1. Prior Art Skin Cooling
The principal methods presently used for skin cooling before or during the laser treatment involve the use of a cold contacting window or cryogenic spray device. Cryogenic spray directly to the skin may reduce a skin temperature below 0 C but can freeze the skin and cause significant damage to it. Typical cold contacting windows of the prior art utilize ice water at 0 C can cool the surface of the skin to as low as about 4 C. But prior art ice water cooled cold contact window devices are inadequate to remove enough heat to prevent unwanted surface tissue damage in many applications.
Three prior art techniques are described in the following United States patents: C. Chess, Apparatus for treating cutaneous vascular lesions, U.S. Pat. No. 5,486,172; Anderson et al., U.S. Pat. No. 5,595,568; and C. Chess, Method for treating cutaneous vascular lesions, U.S. Pat. No. 5,282,797. All of these devices and methods provide for the cooling of the skin down to temperatures of about 4 C but not below it.
A different technique is described by J. S. Nelson et al., in the article “Dynamic Epidermal Cooling in Conjunction With Laser-Induced Photothermolysis of Port Wine Stain Blood Vessels, Lasers in Surgery and Medicine 1996;19:224-229. In this technique the direct cryogenic spray to the skin surface is used before the laser pulse delivery. This method is normally not satisfactory. The surface gets too cold and the subsurface layers are not sufficiently cooled so that unwanted damage occurs at the surface because the tissue gets too cold from the cryogen and/or unwanted damage occurs in the immediate subsurface layers because the tissue gets too hot from the laser beam.
2. Selective Photothermolysis
Dr. Leon Goldman and Dr. Rex Anderson developed the technique known as selective photothermolysis. This technique involves the use of a laser beam having absorption in targeted tissue much higher than in other tissue. Blood has very high absorption of laser radiation at about 530 nm and 575-590 nm. These frequencies are available from the double frequency Nd-YAG laser producing 532 nm light and by an argon laser producing 530 nm. Dye lasers at 577, 585 and 587 are also used in techniques that target blood vessels. These techniques have proven very successful in treating conditions known as port wine stains when the blood vessels are small and near the skin surface. The techniques do not work well for deeper, larger blood vessels.
What is needed is a better laser surgery cooling method to better control tissue temperature during laser treatments.
The present invention provides a laser treatment device and process with controlled cooling. The device contains a cooling element with high heat conduction properties, which is transparent to the laser beam. A surface of the cooling element is held in contact with the tissue being treated while at least one other surface of the cooling element is cooled by the evaporation of a cryogenic fluid. The cooling is coordinated with the application of the laser beam so as to control the temperatures of all affected layers of tissues. In a preferred embodiment useful for removal of wrinkles and spider veins, the cooling element is a sapphire plate. A cryogenic spray cools the top surface of the plate and the bottom surface of the plate is in contact with the skin. In preferred embodiments the wavelength of the laser beam is chosen so that absorption in targeted tissue is low enough so that substantial absorption occurs throughout the targeted tissue. In a preferred embodiment for treating large spider veins with diameters in the range of 1.5 mm, Applicants use an Er:Glass laser with a wavelength of 1.54 microns. In another embodiment a cooling rod is used. A first surface is in contact with the skin surface being treated and an opposite surface is contained in an anticondensation oil chamber that is optically connected to a laser beam delivering fiber optic cable. In this preferred embodiment the temperature of the rod is monitored with a thermocouple which provides a feedback signal to a processor which controls the cooling and the laser power to provide proper regulation of temperatures at all affected tissue layers. Preferred embodiments the device may be used for treating port wine stains especially those stains involving relatively deep larger blood vessels which as indicated in the Background section are not well treated with photothermalyses techniques using highly preferentially absorbed wavelengths of about 530 nm and 575 to 590 nm.
FIGS. 7A1-7 and 7B1-7 are temperature profile charts.
Preferred embodiments of the present invention can be described by reference to the figures.
A section of human skin with a cooling cryogenic rod device 1 in accordance with the present invention is shown in
The section of skin is first cleaned with alcohol to remove moisture to prevent a condensation on the contacting surface of the rod and in order to dehydrate the skin surface to reduce the epidermal damage from the light interaction with water. When the valve of the nozzle is opened the cryogen coolant is sprayed micro drops into the cooling chamber. The cryogenic mist flows around the sapphire. The micro drops contact the rod and vaporize from the surface of the rod by the rod heat reducing the rod temperature dramatically fast. The whole rod becomes cold almost instantly because of the high thermoconductivity of sapphire. The sapphire rod cools the surface of the skin by heat exchange.
A preferred application of the device shown in
The processor will stop the lasing if thermocouple 8 indicates an excessive temperature which in this procedure would be about 60 C. The thermocouple 8 is preferably calibrated to the temperature of the skin located in one millimeter from the rod edge. The difference between the temperature of the skin under the rod and in 1 mm from the rod edge is varied from 10 C to 20 C and depending upon the rod design. Applicant has performed computer simulations to determine temperature profiles in the case of laser treatments, at wavelengths of 585 nm, 632 nm, 1064 nm, 1340 nm, and 1540 nm, with and without surface cooling. FIGS. 7A1-7 show the effects of a 20J/cm2, 0.54 mm diameter blood vessel, and 0.5 mm below the skin surface, with no surface cooling. FIGS. 7B1-7 represent similar conditions with surface cooling with a −15° C. sapphire glass rod for 0.5 sec. These simulations show the advantages of the Nd:YAG at 1064 nm, the Nd:YAP at 1340 nm and the Er:Glass at 1540 nm as compared to the shorter wavelength lasers that are more highly absorptive in blood. This effect is seen clearly by comparing
Mechanical contact, optical, electrical or other sensor can be used to trigger the time delay circuit after the cold rod touches the skin for the definite time. The time delay is defined by the procedure and by the anatomical structure of the skin and blood vessel.
It is known that an effective treatment for the removal of wrinkles is to destroy a line of tissue just below the epidermis at the bottom of the wrinkle valley. Scar tissue forms in the place of the destroyed tissue pushing up the bottom of the valley and effectively removing the wrinkle. The problem is how do you destroy the tissue below the epidermis without also destroying the epidermis and thus replacing an ugly wrinkle with an ugly scar. The present invention provides the solution. Using substantially the same procedure as described above, the tissue at the bottom of the wrinkle valley is destroyed without any significant damage to the epidermis. Details and parameters are outlined below.
The laser device used in this preferred embodiment is a free running mode Er:Glass pulse laser that has the spike in the range of 1.54 microns. Light in this range has minimal scattering losses in the skin tissue and is readily absorbed in the skin fluids. Laser parameters such as pulse width, energy density, repetition rate can be selected to best fit the skin and the treated lesion of the patients. The parameters for two specific examples which have been utilized with good results for wrinkle removal and leg vein treatment are shown in Table 1:
Each point on the skin receives a high energy density illumination for about 2 milliseconds. Some of the light is reflected. Of the light which is not reflected a significant portion of the energy of each pulse penetrates to the depth up to 1-1.5 mm and is absorbed by the skin fluids.
Operating within the parameters specified is important. They have been chosen to preferentially cool the skin surface protecting epidermis and to heat the subepidertnal collagen or blood vessels to the level of irreversible changes in the coagulated skin tissue and blood vessel proteins. It must be chosen so that a large amount of energy is deposited in the skin quickly so that the temperature of the targeted tissue rises rapidly to about or slightly above 70° C. The cooling applied to the surface for about half a second is enough to protect epidermis from the temperature increasing to 70 C. Thus the above procedure can be used effectively for treatment spider veins.
In another embodiment of the present invention the Nd:YAG laser is used. The wavelength of the beam is at 1.06 microns. Light at this wavelength has a very low absorption in skin tissue and in interstitial fluids. Absorption in blood is also low but is about twice that of general skin tissue and interstitial fluids. Therefore, this wavelength is very good for treating telagiactasia with dimensions in the range of 1 mm and greater and large spider veins in the range of 1.5 mm. Table 2 gives some preferred parameters for treating a 1 mm telagiactasia and a 1.5 mm-spjider vein.
A long pulse Nd:YAG with a pulse width of about 100-200ms. Pulses in this range have been utilized with good results for destruction of skin tumor angiogenesis and coagulation of hair follicular blood vessels at depths of up to 5.0 mm. Some preferred parameters are given in Table 3. Preferably, cooling is provided for a period of about 1 to 2 seconds prior to the illumination.
Estimation of temperature rise in skin can be made by calculating laser light fluence in skin and estimating energy deposition per unit volume of skin. Effect of contact skin surface cooling was accounted based on the solution of heat transfer equations.
In order to choose proper light fluence in skin the following optical properties of tissue have been used:
At a wavelength of 1.54 micron, absorption in tissues is determined primarily by their water content. Water content of whole blood is more then 90%, whereas in dermis and epidermis it is about twice less. For this reason absorption of IR radiation and temperature rise in blood is about two times higher than in surrounding dermis tissue. Once fluence in the skin is calculated and a depth of absorption is estimated, the temperature rise ΔT due to light absorption can be roughly estimated as follows:
ΔT=Q/mc
where skin density is about 1.15 g/cm3 and specific heat of skin about 3.8J/Cgm.
Effect of skin surface cooling on temperature distribution in skin have been estimated by solving heat transfer equation in semi infinite skin tissue with boundary conditions corresponding to constant −5° C. temperature of the surface (or other constant temperature of the sapphire rod). Temperature distribution in ° C. in skin then can be calculated by formula:
T(z,t)=37*erf(z/2 αct),
where erf refers to the Gausian error function, and z is the depth into the tissue, t is time lapse in seconds from the start of the contact skin cooling and α=10−4(cm2/sec) is thermal diffusivity of skin dermis. Skin temperature was found by superposition of laser heating and surface cooling effects.
Various elaborate computer programs are available for more precise estimate of temperature distribution within the skin as a function of time. Applicants have made analysis using a Monte-Carlo computer code specifically modified for skin thermodynamic analysis and some of the results are shown in FIGS. 7A1-7 and 7B1-7 which were discussed above. Cooling experiments have been performed by using different configurations of the cooling element for the different applications. For these applications, one of the alternative embodiments is recommended.
The reader should understand that devices according to the present invention work by destroying living tissue. Hopefully the destroyed tissue is unwanted tissue and is quickly replaced by new tissue produced by the body's natural ability to repair damaged and destroyed skin tissue. Care should be taken to minimize unwanted tissue destruction. Applicants recommend that tests be performed prior to use of the device in the manner disclosed above. A test station could be constructed using a plastic material having thermal properties similar to human skin and equipping it with fast response thermocouples located at various depths and positions below the surface. The thermocouples should be connected to the real time monitors so that the technician and the patient can see the thermal effects produced by the device prior to actual use on the patient.
A second embodiment involves the use of a cryogenically cooled diamond cooling element as shown in
The flattened diamond rod is transparent to the laser beam. It is applied to the part of the cleaned skin to be treated. The nozzle valve opens the shutter and the cryogenic spray flows to the chamber around this window. When the window is cold the “ready” light will be switched-on. The energy delivery procedure can be started. This device is good for the large area irradiation such as subsurface tumor interstitial thermotherapy with a high frequency electromagnetic radiation.
A third embodiment for practicing this invention is to use a patterned rod to the surface of the skin in order to have damaged and healthy areas under the skin surface.
A laser light is sent through the cooled rod to the surface of the skin does not penetrate through the copper stripes. But the contacting surface of the rod has an almost uniform temperature distribution. It means that the surface of the skin is cooled uniformly. But under skin damage is not uniform having irradiated and not irradiated healthy spots. The reason to have these healthy untouched spots around the damaged tissue is to use the capacity of healthy spot tissue and cells for the fast immune response and wound healing process.
This embodiment is essentially the same as the first one described above except that the rod tip, which is connected to the fiber optics has concave form for the self-collimating beam properties.
This embodiment is essentially the same as the first one described above except that the cylindrical element is placed in the cooling chamber horizontally (see
The device disclosed herein can be used in reverse. That is, surface tissue destruction can be provided by the very cold surface of the tip of the sapphire rod. Preferably, the skin is pre-warmed with a low energy laser pulse of about one-half the values specified above which should cause no damage but will provide warmth which will minimize tissue destruction caused below the surface. This process is good for freezing of warts and certain types of surface skin cancers.
In an additional embodiment pre and post cooling is provided by transparent circular part 20 as shown in
Another preferred embodiment is shown in
It is very important for all of these embodiments and in other embodiments that will be apparent to persons skilled in the art that the cooling rod has a very high thermoconductivity coefficient and low absorption of the irradiating light. The substance used for the cryogenic cooling can be chosen based on the particular application. The important thing is to use a proper time of cooling in order to reach a required low temperature of the tissue at the required depth. Persons skilled in the art will recognize that certain material and configuration of the rod, container, coolant and connector will be preferred for different skin type, different lesions and different applications. The reader should note that the preferred embodiment of this invention can be used without this laser to provide cryogenic treatment to surface skin lesions. The same skin cooling can be provided with about 1/10 the cryogen as direct open spray. An important application of the device for cryogenic treatment is to promote lymphatic drainage by cold therapy. Skin rejuvenation begins with flushing of the lymphatic system to remove dead proteins and other debris. Thermal receptors in the lymphatic system are effectively stimulated by the presence of cold applied to the skin surface. Current techniques for lymphatic drainage by cold therapy include spray and ice, both of which are messy and offer poor control of the skin temperature. The device shown in
While the above description contains many specifications, the reader should not construe these as limitations on the scope of the invention, buy merely as exemplifications of preferred embodiments thereof. Those skilled in the art will envision many other possible variations are within its scope. Accordingly the reader is requested to determine the scope of the invention by the appended claims and their legal equivalents, and not by the examples which have been given.
This application is a continuation-in-part application of U.S. Ser. No. 09/174,065 filed Oct. 16, 1998 U.S. Pat. No. 6,059,820. This invention relates to devices and methods for laser treatment and in particular to laser treatment with surface cooling.This application is a continuation reissue application of Reissue application Ser. No. 11/250,139, filed Oct. 13, 2005, which is a reissue application of U.S. Pat. No. 6,632,219 (application Ser. No. 09/523,225, filed Mar. 10, 2000), which is a continuation-in-part of application Ser. No. 09/174,065, filed Oct. 16, 1998 and now U.S. Pat. No. 6,059,820. Reissue application Ser. No. 11/250,139 is hereby incorporated by reference herein in its entirely for all purposes. Notice: More than one reissue application has been filed for the reissue of U.S. Pat. No. 6,632,219. The reissue applications are Reissue application Ser. No. 11/250,139 (now U.S. Pat. No. Re. 42,594), continuation Reissue application Ser. No. 13/165,153 (now U.S. Pat. No. Re. 43,881), and continuation Reissue application Ser. No. 13,165,181 (the present application), all of which are reissues of U.S. Pat. No. 6,632,219.
Number | Name | Date | Kind |
---|---|---|---|
3622743 | Muncheryan | Nov 1971 | A |
4122853 | Smith | Oct 1978 | A |
4573465 | Sugiyama et al. | Mar 1986 | A |
4587396 | Rubin | May 1986 | A |
4653495 | Nanaumi | Mar 1987 | A |
4718416 | Nanaumi | Jan 1988 | A |
4733660 | Itzkan | Mar 1988 | A |
4775361 | Jacques et al. | Oct 1988 | A |
4930504 | Diamantopoulos et al. | Jun 1990 | A |
4976709 | Sand | Dec 1990 | A |
5000752 | Hoskin et al. | Mar 1991 | A |
5104392 | Kittrell et al. | Apr 1992 | A |
5106387 | Kittrell et al. | Apr 1992 | A |
5128509 | Black et al. | Jul 1992 | A |
5178617 | Kuizenga et al. | Jan 1993 | A |
5192278 | Hayes et al. | Mar 1993 | A |
5282797 | Chess | Feb 1994 | A |
5302259 | Birngruber | Apr 1994 | A |
5312395 | Tan et al. | May 1994 | A |
5312396 | Feld et al. | May 1994 | A |
5336217 | Buys et al. | Aug 1994 | A |
5339347 | Slatkin et al. | Aug 1994 | A |
5344418 | Ghaffari | Sep 1994 | A |
5360447 | Koop | Nov 1994 | A |
5411502 | Zair | May 1995 | A |
5421337 | Richards-Kortum et al. | Jun 1995 | A |
5423803 | Tankovich et al. | Jun 1995 | A |
5474549 | Ortiz et al. | Dec 1995 | A |
5486172 | Chess | Jan 1996 | A |
5531740 | Black | Jul 1996 | A |
5546214 | Black et al. | Aug 1996 | A |
5558666 | Dewey et al. | Sep 1996 | A |
5582752 | Zair | Dec 1996 | A |
5586981 | Hu | Dec 1996 | A |
5595568 | Anderson et al. | Jan 1997 | A |
5611795 | Slatkine et al. | Mar 1997 | A |
5616140 | Prescott | Apr 1997 | A |
5618284 | Sand | Apr 1997 | A |
5618285 | Zair | Apr 1997 | A |
5624434 | Abergel et al. | Apr 1997 | A |
5624435 | Furumoto et al. | Apr 1997 | A |
5628744 | Coleman et al. | May 1997 | A |
5632741 | Zavislan et al. | May 1997 | A |
5643252 | Waner et al. | Jul 1997 | A |
5655547 | Karni | Aug 1997 | A |
5713364 | DeBaryshe et al. | Feb 1998 | A |
5733278 | Slatkine et al. | Mar 1998 | A |
5735844 | Anderson et al. | Apr 1998 | A |
5746735 | Furumoto et al. | May 1998 | A |
5759200 | Azar | Jun 1998 | A |
5798498 | Zair | Aug 1998 | A |
5807386 | Slatkine et al. | Sep 1998 | A |
5810801 | Anderson et al. | Sep 1998 | A |
5814040 | Nelson et al. | Sep 1998 | A |
5814042 | Zair | Sep 1998 | A |
5817089 | Tankovich et al. | Oct 1998 | A |
5820626 | Baumgardner | Oct 1998 | A |
5830208 | Muller | Nov 1998 | A |
5843073 | Sinofsky | Dec 1998 | A |
5860967 | Zavislan et al. | Jan 1999 | A |
5860968 | Wojcik et al. | Jan 1999 | A |
5865754 | Sevick-Muraca et al. | Feb 1999 | A |
5879326 | Godshall et al. | Mar 1999 | A |
5879346 | Waldman et al. | Mar 1999 | A |
5885211 | Eppstein et al. | Mar 1999 | A |
5897549 | Tankovich | Apr 1999 | A |
5906609 | Assa et al. | May 1999 | A |
5908415 | Sinofsky | Jun 1999 | A |
5925035 | Tankovich | Jul 1999 | A |
5938657 | Assa et al. | Aug 1999 | A |
5947956 | Karell | Sep 1999 | A |
5957915 | Trost | Sep 1999 | A |
5964749 | Eckhouse et al. | Oct 1999 | A |
5968033 | Fuller et al. | Oct 1999 | A |
5970983 | Karni et al. | Oct 1999 | A |
5976123 | Baumgardner et al. | Nov 1999 | A |
5980512 | Silberg | Nov 1999 | A |
5983900 | Clement et al. | Nov 1999 | A |
5984915 | Loeb et al. | Nov 1999 | A |
5995265 | Black et al. | Nov 1999 | A |
5995866 | Lemelson | Nov 1999 | A |
5997530 | Nelson et al. | Dec 1999 | A |
6015404 | Altshuler et al. | Jan 2000 | A |
6022316 | Eppstein et al. | Feb 2000 | A |
6027496 | Loomis et al. | Feb 2000 | A |
RE36634 | Ghaffari | Mar 2000 | E |
6036684 | Tankovich et al. | Mar 2000 | A |
6050990 | Tankovich et al. | Apr 2000 | A |
6059820 | Baronov | May 2000 | A |
6063108 | Salansky et al. | May 2000 | A |
6074384 | Brinkmann et al. | Jun 2000 | A |
6083217 | Tankovich | Jul 2000 | A |
6096029 | O'Donnell, Jr. | Aug 2000 | A |
6096031 | Mitchell et al. | Aug 2000 | A |
6104959 | Spertell | Aug 2000 | A |
6106514 | O'Donnell, Jr. | Aug 2000 | A |
RE36872 | Zair | Sep 2000 | E |
6113559 | Klopotek | Sep 2000 | A |
6120497 | Anderson et al. | Sep 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6149644 | Xie | Nov 2000 | A |
6149645 | Tobinick | Nov 2000 | A |
6152917 | Tankovich | Nov 2000 | A |
6162211 | Tankovich et al. | Dec 2000 | A |
6165170 | Wynne et al. | Dec 2000 | A |
6168590 | Neev | Jan 2001 | B1 |
6171301 | Nelson et al. | Jan 2001 | B1 |
6171302 | Talpalriu et al. | Jan 2001 | B1 |
6173202 | Eppstein | Jan 2001 | B1 |
6176854 | Cone | Jan 2001 | B1 |
6183773 | Anderson | Feb 2001 | B1 |
6197020 | O'Donnell, Jr. | Mar 2001 | B1 |
6219575 | Nemati | Apr 2001 | B1 |
6235015 | Mead, III et al. | May 2001 | B1 |
6241753 | Knowlton | Jun 2001 | B1 |
6245060 | Loomis et al. | Jun 2001 | B1 |
6248103 | Tannenbaum et al. | Jun 2001 | B1 |
6251099 | Kollias et al. | Jun 2001 | B1 |
6251100 | Flock et al. | Jun 2001 | B1 |
6264649 | Whitcroft et al. | Jul 2001 | B1 |
6267771 | Tankovich et al. | Jul 2001 | B1 |
6273884 | Altshuler et al. | Aug 2001 | B1 |
6273885 | Koop et al. | Aug 2001 | B1 |
6315772 | Marchitto et al. | Nov 2001 | B1 |
6325769 | Klopotek | Dec 2001 | B1 |
6328733 | Trost | Dec 2001 | B1 |
6387089 | Kreindel et al. | May 2002 | B1 |
6406474 | Neuberger et al. | Jun 2002 | B1 |
6413267 | Dumoulin-White et al. | Jul 2002 | B1 |
6443946 | Clement et al. | Sep 2002 | B2 |
6443978 | Zharov | Sep 2002 | B1 |
6445491 | Sucha et al. | Sep 2002 | B2 |
6468229 | Grace et al. | Oct 2002 | B1 |
6475138 | Schechter et al. | Nov 2002 | B1 |
6508813 | Altshuler | Jan 2003 | B1 |
6514278 | Hibst et al. | Feb 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6530915 | Eppstein et al. | Mar 2003 | B1 |
6537270 | Elbrecht et al. | Mar 2003 | B1 |
6572637 | Yamazaki et al. | Jun 2003 | B1 |
6575963 | Van Saarloos et al. | Jun 2003 | B1 |
6579283 | Tobinick | Jun 2003 | B1 |
6605080 | Altshuler et al. | Aug 2003 | B1 |
6607523 | Asah et al. | Aug 2003 | B1 |
6632219 | Baranov et al. | Oct 2003 | B1 |
6680999 | Garcia | Jan 2004 | B1 |
6685699 | Eppstein et al. | Feb 2004 | B1 |
6743211 | Prausnitz et al. | Jun 2004 | B1 |
6758845 | Weckwerth et al. | Jul 2004 | B1 |
6881212 | Clement et al. | Apr 2005 | B1 |
7204832 | Altshuler et al. | Apr 2007 | B2 |
Number | Date | Country |
---|---|---|
0827219 | Mar 1998 | EP |
0827716 | Mar 1998 | EP |
58086787 | May 1983 | JP |
01191801 | Aug 1989 | JP |
09285471 | Nov 1997 | JP |
9824502 | Jun 1998 | WO |
9824507 | Jun 1998 | WO |
9824514 | Jun 1998 | WO |
9927997 | Jun 1999 | WO |
0139834 | Jun 2001 | WO |
Entry |
---|
US 6,344,051, 02/2002, Dumoulin-White et al. (withdrawn) |
Anderson, R.R. et. Al., “Laser-Tissue Interactions,” Cosmetic Laser Surgery, 2000, pp. 1-30, Mosby. |
McKenzie, A.L, “A Three-Zone Model of Tissue Damage by a CO2 Laser,” Phys. Med. Boil, 1986, pp. 967-983, vol. 31, No. 9. |
Partovi, F. et al., “A Model for Thermal Ablation of Biological Tissue Using Laser Radiation,” Lasers in Surgery and Medicine, 1987, pp. 141-154, vol. 7. |
Fitzpatrick, R.E., “Laser Hair Transplanation. Tissue effects of Laser Parameters,” Dermatol. Surg., Dec. 1995, pp. 1042-1046, vol. 21. No. 12. |
Grevelink, J.M., “Laser Hair Tranplanation,” Dermatolog Clinics, Jul. 1, 1997, pp. 479-486, vol. 15, Issue 3. |
Rubach, B.W. et al., “Histological and Clinical Evaluation of Facial Resurfacing Using a Carbon Dioxide Laser with the Computer Pattern Generator,” Arch. Otolaryngol. Head Neck Surg., Sep. 1997, pp. 929-934, vol. 123, No. 9. |
Unger, W.P. et al., “Laser Hair Tranplantation,” J. Dermatol. Surg. Oncol., Aug. 1994, pp. 515-521, vol. 20, No. 8. |
Unger, W.P. “Laser Hair Transplanation III. Computer-Assisted Laser Tranplanting,” Dermatol. Surg. Dec. 1995, pp. 1047-1055, vol. 21, No. 12. |
European Office Action, European Application No. 00916279.3, Aug. 28, 2006, 4 pages. |
European Office Action, European Application No. 00916279.3, Dec. 15, 2006, 4 pages. |
European Search Report, European Application No. 00916279.3, May 11, 2005, 2 pages. |
Nelson, J.S. et al., “Dynamic Epidermal Cooling in Conjunction with Laser-Induced Photothermolysis of Port Wine Stain Blood Vessels,” Lasers in Surgery and Medicine, 1996, pp. 224-229, vol. 19. |
PCT international Search Report, PCT/US00/064085, Jul. 88, 2000, 1 page. |
Fujii, et al., Fibre bundle scanner for laser photocoagulation treatment. Optics and Laser Technology, Feb. 1982, pp. 39-41. |
Fujii, et al., Multispot laser photogoagulation system using a fiber bundle scanner, Applied Optics, vol. 21, No. 19, Oct. 1982, pp. 3437-3442. |
Apfelberg, et al., Dot or Pointillistic Method for Improvement in Results of Hypertrophic Scarring in the Argon Laser Treatment of Portwine Hemangiomas, Lasers in Surgery and Medicine, 6:552-558 (1987). |
Apfelberg, Intralesional Laser Photocoagulation—Steroids as an Adjunct to Surgery for Massive Hemangiomas and Vascular Malformations, Atherton Plastic Surgery and Laser Center, Atherton, CA 1995, pp. 144-149. |
Manstein, D. et al., “Spatially Confined Photothermolysis of dermal targets using an IR-fiberlaser in combination with focusing and contact cooling,” American Society for Laser Medicine and Surgery, 2002, Abstract 92, p. 28. |
Number | Date | Country | |
---|---|---|---|
Parent | 11250139 | Oct 2005 | US |
Child | 09523225 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09174065 | Oct 1998 | US |
Child | 09523225 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09523225 | Mar 2000 | US |
Child | 13165181 | US | |
Parent | 09523225 | Mar 2000 | US |
Child | 11250139 | US |